Cover Image

OP 7.3 - 00139 Pre-treatment Interruption Plasma Metabolites and Glycans Correlate with Time to HIV Rebound and Reservoir Size in ACTG A5345

Saved in:

Bibliographic Details
Main Authors:	L.B. Giron (Author), X. Yin (Author), S.G. Deeks (Author), R.T. Gandhi (Author), A. Landay (Author), Q. Liu (Author), B.J. Macatangay (Author), D.M. Smith (Author), J.Z. Li (Author), M. Abdel-Mohsen (Author)
Format:	Book
Published:	Elsevier, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Phenotypic diversity in clinical and manometric characteristics of pediatric patients with ACTG2 mutations
by: Sindhu Pandurangi, et al.
Published: (2021)

Four Weeks of Treatment With Rifaximin Fails to Significantly Alter Microbial Diversity in Rectal Samples of HIV-Infected Immune Non-Responders (ACTG A5286) Which May be Attributed to Rectal Swab Use
by: Brett B. Williams, et al.
Published: (2019)

Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray.
by: Angela van Diepen, et al.
Published: (2012)

Decoding the mannose receptor-mAb interaction: the importance of high-mannose N-glycans and glycan-pairing
by: Julia Baumeister, et al.
Published: (2024)

Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity
by: Esteban Cruz, et al.
Published: (2021)

The Role of Glycans in Immune Cell Functions
Published: (2020)

Editorial: Action and Mechanism of Herbal Glycans
by: Shaoping Li, et al.
Published: (2022)

Glycan Diversity in Fungi, Bacteria and Sea Organisms
by: Eliana Barreto-Bergter
Published: (2016)

Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma
by: Yonghyun Choi, et al.
Published: (2023)

OP 8.4 - 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption
by: H. King, et al.
Published: (2022)

PP 1.13 - 00078 CTL epitopes from structurally important hiv proteins are identified in rebound HIV
by: E. Lee, et al.
Published: (2022)

Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint
by: M. Abdel-Mohsen, et al.
Published: (2019)

Addressing Roles for Glycans in Immunology using Chemical Biology
Published: (2020)

Marine Non-Glycosaminoglycan Sulfated Glycans as Potential Pharmaceuticals
by: Vitor H. Pomin
Published: (2015)

Epigenetic modification in the expression of p73 p73 - epigenetic target for anticancer therapy
by: Faiza Naseer, et al.
Published: (2019)

PP 4.11 - 00126 Autologous Neutralizing Antibodies Increase with Early Antiretroviral Therapy and Shape HIV Rebound after Treatment Interruption
by: E. Esmaeilzadeh, et al.
Published: (2022)

A case report of a 30-year-old male with megacystis-microcolon-intestinal hypoperistalsis syndrome with de novo ACTG2 gene mutation
by: Knežević Violeta V., et al.
Published: (2023)

Early adiposity rebound: predictors and outcomes
by: Alessandra Li Pomi, et al.
Published: (2024)

Rebound pain: Undesired, yet unexplored
by: Pradeep Bhatia, et al.
Published: (2022)

Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease
by: Zhang Y, et al.
Published: (2021)

Obstetric antiphospholipid syndrome: An approach from glycans of the immunoglobulin G
by: Angela Maria Alvarez, et al.
Published: (2021)

Sobre este número 73
by: Revista Colombiana de Educación
Published: (2017)

Editorial JVE 7.3
Published: (2021)

OP 4.6 - 00185 No associations between magnitudes of HIV-specific CTL responses on stable art and subsequent decay of intact proviruses or cell-associated HIV mRNA
by: A. Ward, et al.
Published: (2022)

Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV
by: Minhee Kang, et al.
Published: (2023)

Barcoded viruses facilitate tracking changes to the composition of the rebound-competent reservoir
by: B. Keele, et al.
Published: (2019)

OP 2.7 - 00057 The latency reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific CD8+ T-cells
by: D.C. Copertino, et al.
Published: (2022)

Plant Glycobiology - a sweet world of lectins, glycoproteins, glycolipids and glycans
by: Nausicaa Lannoo
Published: (2014)

Glycans instructing immunity: the emerging role of altered glycosylation in clinical immunology
by: Jonathan J Lyons, et al.
Published: (2015)

A glyco-engineering approach for site-specific conjugation to Fab glycans
by: Maria L. Jaramillo, et al.
Published: (2023)

N-glycans Profiling in Pilocarpine Induced Status Epilepticus in Immature Rats
by: Kapoor S., et al.
Published: (2022)

Comparing different domains of analysis for the characterisation of N-glycans on monoclonal antibodies
by: Sara Carillo, et al.
Published: (2020)

USP Reference Standard Monoclonal Antibodies: Tools to Verify Glycan Structure
by: Jingzhong Guo, et al.
Published: (2022)

OP 2.5 - 00048 Targeting the SIV reservoir with Alemtuzumab
by: B. Varco-Merth, et al.
Published: (2022)

Origin of rebound virus in chronically SIV-infected monkeys following treatment discontinuation
by: D. Barouch, et al.
Published: (2019)

A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodies
by: Shen Luo, et al.
Published: (2024)

Multivariate quantitative analysis of glycan impact on IgG1 effector functions
by: Tamara Cvijić, et al.
Published: (2024)

Analysis of rebounded balls in a team handball match
by: Ante Burger, et al.
Published: (2013)

Beta-blocker Rebound Phenomenon in an Adolescent with Graves' Disease
by: Ahmet Anık
Published: (2022)

Early Adiposity Rebound and Obesity in Children with Congenital Hypothyroidism
by: Shou-Yen Chen, et al.
Published: (2013)